Literature DB >> 23188681

Histopathology of vascular anomalies.

Amir Aboutalebi1, Chad J Jessup, Paula E North, Martin C Mihm.   

Abstract

Vascular anomalies may be appropriately classified into two broad categories, vascular tumors and vascular malformations, which are distinguished by the presence of cellular proliferation in contrast to aberrations in morphogenesis, respectively. This system of classification is based upon histological features that may in large part be differentiating, but nevertheless, may show morphological overlap. Advances in immunophenotyping allow for more precise diagnoses as well as further delineation of cell origins. In the discussion, we present the clinical, histological, and, when applicable, the immunophenotypic presentation of vascular anomalies commonly seen in infancy and early childhood. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2012        PMID: 23188681     DOI: 10.1055/s-0032-1329929

Source DB:  PubMed          Journal:  Facial Plast Surg        ISSN: 0736-6825            Impact factor:   1.446


  4 in total

1.  Adhesion molecule-mediated hippo pathway modulates hemangioendothelioma cell behavior.

Authors:  Masayuki Tsuneki; Joseph A Madri
Journal:  Mol Cell Biol       Date:  2014-09-29       Impact factor: 5.069

2.  Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.

Authors:  Graham M Strub; Andrew L Kirsh; Mark E Whipple; Winston P Kuo; Rachel B Keller; Raj P Kapur; Mark W Majesky; Jonathan A Perkins
Journal:  JCI Insight       Date:  2016-09-08

Review 3.  The changing face of complicated infantile hemangioma treatment.

Authors:  Deanna Menapace; Mario Mitkov; Richard Towbin; Marcia Hogeling
Journal:  Pediatr Radiol       Date:  2016-07-23

4.  Iatrogenic Kaposi's sarcoma following therapy for rheumatoid arthritis.

Authors:  Beata Bergler-Czop; Ligia Brzezińska-Wcisło; Magdalena Kolanko
Journal:  Postepy Dermatol Alergol       Date:  2016-05-16       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.